[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioPharmCatalyst [@BPharmCatalyst](/creator/twitter/BPharmCatalyst) on x 29.9K followers Created: 2021-02-25 23:49:48 UTC BioPharmCatalyst updates 02/25/21: $PAND acquired by MRK +133% $SRPT FDA Approval $ASLN private placement +27% $NVCR trial delays -XX% $TCDA -XX% AH Pipeline updates $AKBA $ASLN $ASMB $CARA $CMRX $EIDX $GKOS $ICPT $NVCR $REGN $YMAB $ZGNX XX engagements  **Related Topics** [$zgnx](/topic/$zgnx) [$ymab](/topic/$ymab) [$regn](/topic/$regn) [$icpt](/topic/$icpt) [$eidx](/topic/$eidx) [$cmrx](/topic/$cmrx) [$cara](/topic/$cara) [$asmb](/topic/$asmb) [Post Link](https://x.com/BPharmCatalyst/status/1365086626855100417)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioPharmCatalyst @BPharmCatalyst on x 29.9K followers
Created: 2021-02-25 23:49:48 UTC
BioPharmCatalyst updates 02/25/21:
$PAND acquired by MRK +133% $SRPT FDA Approval $ASLN private placement +27% $NVCR trial delays -XX% $TCDA -XX% AH
Pipeline updates $AKBA $ASLN $ASMB $CARA $CMRX $EIDX $GKOS $ICPT $NVCR $REGN $YMAB $ZGNX
XX engagements
Related Topics $zgnx $ymab $regn $icpt $eidx $cmrx $cara $asmb
/post/tweet::1365086626855100417